NOUVEAUX DERIVES DE 2H-PYRIDAZINE-3-ONE, COMPOSITIONS PHARMACEUTIQUES CONTENANT CES DERIVES ET PROCEDE DE PREPARATION DE L'INGREDIENT ACTIF

L'invention réfère plus particulièrement aux nouveaux dérivés 2H-pyridazine-3- de la formule. The invention refers to novel 2H-pyridazine-3-one derivatives of the formula I, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient. The novel com...

Full description

Saved in:
Bibliographic Details
Main Authors PALLAGI, KATALIN, SIMIG, GYULA, KOTAY NAGY, PETER, SZENASI, GABOR, MIKLOSNE KOVACS, ANIKO, RACZNE BAJNOGEL, JUDIT, LEVAY, GYORGY, SCHMIDT, EVA, WELLMANN, JANOS, BARKOCZY, JOZSEF, GACSALYI, ISTVAN, EGYED, ANDRAS
Format Patent
LanguageFrench
Published 02.05.2006
Edition7
Online AccessGet full text

Cover

More Information
Summary:L'invention réfère plus particulièrement aux nouveaux dérivés 2H-pyridazine-3- de la formule. The invention refers to novel 2H-pyridazine-3-one derivatives of the formula I, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient. The novel compounds possess neuroleptic effect and can be used, primarily, for the treatment of schizophrenia. In formula I, R stands for a hydrogen atom or a C1-4, alkyl group, X and Y represent, independently, a hydrogen atom, a halogen atom or a group of the formula II, with the proviso that one of X and Y means always a group of the formula II, and then the other one stands for a hydrogen atom or a halogen atom, wherein in formula II n has a value of 1 or 2.
Bibliography:Application Number: MA20040027487